Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022)
(1) Background: With the massive demand for the use and commercialization of medicinal cannabidiol (CBD) products, new randomized clinical trials (RCTs) are being published worldwide, with a constant need for safety and efficacy evaluation. (2) Methods: We performed an update on a systematic review...
Saved in:
Main Authors: | José Diogo R. Souza (Author), Julia Cozar Pacheco (Author), Giordano Novak Rossi (Author), Bruno O. de-Paulo (Author), Antonio W. Zuardi (Author), Francisco S. Guimarães (Author), Jaime E. C. Hallak (Author), José Alexandre Crippa (Author), Rafael G. Dos Santos (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
∆9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
by: José Alexandre Crippa, et al.
Published: (2016) -
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
by: Antonio W. Zuardi, et al.
Published: (2017) -
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
by: Ila M. P. Linares, et al.
Published: (2018) -
Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
by: José Diogo S. Souza, et al.
Published: (2022) -
Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
by: Fernanda Fiel Peres, et al.
Published: (2016)